Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/12/26/2801085/0/en/Atreca-Announces-Asset-Purchase-Agreement-for-Sale-of-Antibody-Related-Assets-and-Materials-to-Immunome.html
https://www.fiercebiotech.com/biotech/atreca-facing-q1-funding-cliff-edge-cuts-headcount-40-second-time-3-months
https://www.globenewswire.com//news-release/2023/11/14/2780574/0/en/Atreca-Reports-Third-Quarter-2023-Financial-Results-and-Announces-Further-Reorganization-to-Support-Exploration-of-Strategic-Alternatives.html
https://www.globenewswire.com//news-release/2023/09/21/2747233/0/en/Atreca-Announces-Agreement-to-Terminate-Lease-and-Departure-of-Chief-Financial-Officer-Herb-Cross.html
https://www.fiercebiotech.com/biotech/atreca-former-big-pharma-darling-axes-lead-drug-40-staff-last-ditch-pivot-adcs
https://endpts.com/atreca-suspends-solid-tumor-antibody-development-cuts-headcount-by-40/
https://www.globenewswire.com/news-release/2023/08/10/2723160/0/en/Atreca-Reports-Second-Quarter-2023-Financial-Results-and-Announces-Corporate-Restructuring.html
https://www.globenewswire.com/news-release/2023/06/05/2681923/0/en/Atreca-Presents-Data-from-Ongoing-Phase-1b-Study-of-ATRC-101-in-Patients-with-Select-Advanced-Solid-Tumors-during-Oral-Abstract-Session-at-the-ASCO-2023-Annual-Meeting.html
https://www.globenewswire.com/news-release/2023/05/10/2666062/0/en/Atreca-Reports-First-Quarter-2023-Financial-Results-and-Recent-Corporate-Developments.html
https://www.globenewswire.com/news-release/2023/04/26/2655648/0/en/Atreca-Announces-Oral-Presentation-of-ATRC-101-Phase-1b-Study-Data-at-ASCO-2023-Annual-Meeting.html